Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wicker

Showing results (201-210 of 233) with videos related to

Pageof 24
Sort By:
Der Urologe. Ausg. A|July 4, 2020
[Movember health care initiative 2019: prostate cancer screening at the University Hospital Frankfurt]M Wenzel, C Humke, S Wicker, et al.
Journal of Autoimmunity|November 18, 2018
A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune diseaseLaurence B Peterson, Charles J M Bell, Sarah K Howlett, et al.
Journal of Autoimmunity|December 3, 2014
Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cellsCharles J M Bell, Yongliang Sun, Urszula M Nowak, et al.
Nature Communications|November 28, 2022
Low-dose IL-2 reduces IL-21<sup>+</sup> T cell frequency and induces anti-inflammatory gene expression in type 1 diabetesJia-Yuan Zhang, Fiona Hamey, Dominik Trzupek, et al.
Diabetologia|March 22, 2024
The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adultsM Loredana Marcovecchio, A Emile J Hendriks, Carl Delfin, et al.
JCI Insight|October 5, 2018
The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetesEleonora Seelig, James Howlett, Linsey Porter, et al.
Wellcome Open Research|August 18, 2017
Capturing the systemic immune signature of a norovirus infection: an n-of-1 case study within a clinical trialAntony J Cutler, Joao Oliveira, Ricardo C Ferreira, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouseLinda S Wicker, Giselle Chamberlain, Kara Hunter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2014
Genetic analysis of autoimmune type 1 diabetes mellitus in mice. 1991John A Todd, Timothy J Aitman, Richard J Cornall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 7, 2015
Ptpn22 and Cd2 Variations Are Associated with Altered Protein Expression and Susceptibility to Type 1 Diabetes in Nonobese Diabetic MiceHeather I Fraser, Sarah Howlett, Jan Clark, et al.
Pageof 24

Showing results (201-210 of 233) with videos related to

Sort By:
Pageof 24
Der Urologe. Ausg. A|July 4, 2020
[Movember health care initiative 2019: prostate cancer screening at the University Hospital Frankfurt]M Wenzel, C Humke, S Wicker, et al.
Journal of Autoimmunity|November 18, 2018
A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune diseaseLaurence B Peterson, Charles J M Bell, Sarah K Howlett, et al.
Journal of Autoimmunity|December 3, 2014
Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cellsCharles J M Bell, Yongliang Sun, Urszula M Nowak, et al.
Nature Communications|November 28, 2022
Low-dose IL-2 reduces IL-21<sup>+</sup> T cell frequency and induces anti-inflammatory gene expression in type 1 diabetesJia-Yuan Zhang, Fiona Hamey, Dominik Trzupek, et al.
Diabetologia|March 22, 2024
The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adultsM Loredana Marcovecchio, A Emile J Hendriks, Carl Delfin, et al.
JCI Insight|October 5, 2018
The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetesEleonora Seelig, James Howlett, Linsey Porter, et al.
Wellcome Open Research|August 18, 2017
Capturing the systemic immune signature of a norovirus infection: an n-of-1 case study within a clinical trialAntony J Cutler, Joao Oliveira, Ricardo C Ferreira, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2004
Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouseLinda S Wicker, Giselle Chamberlain, Kara Hunter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2014
Genetic analysis of autoimmune type 1 diabetes mellitus in mice. 1991John A Todd, Timothy J Aitman, Richard J Cornall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 7, 2015
Ptpn22 and Cd2 Variations Are Associated with Altered Protein Expression and Susceptibility to Type 1 Diabetes in Nonobese Diabetic MiceHeather I Fraser, Sarah Howlett, Jan Clark, et al.
Pageof 24